HIGHLIGHTS
- who: Zheng-Zong Lai and collaborators from the Department and Graduate Institute of Pharmacology, National Defense Medical Center, Taipei, TaiwanDepartment of Biological Sciences, National University of Singapore, Singapore, Singapore have published the research work: Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms, in the Journal: Molecules 2020, 25, x FOR PEER REVIEW of /2020/
- what: The authors evaluated the antiviral efficacy of harringtonine against ZIKV. This study demonstrated that harringtonine would be a favorable potential candidate for the development of anti-ZIKV infection therapies. The authors evaluated the potential anti-ZIKV activity of harringtonine and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.